# IC14 in Adult Patients With Dengue Fever

> **NCT03875560** · PHASE2 · WITHDRAWN · sponsor: **Implicit Bioscience**

## Conditions studied

- Dengue Fever

## Interventions

- **BIOLOGICAL:** IC14
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03875560
- **Lead sponsor:** Implicit Bioscience
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-05
- **Primary completion:** 2020-01
- **Final completion:** 2020-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** withdrawn, no enrollment
- **Last updated:** 2026-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03875560

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03875560, "IC14 in Adult Patients With Dengue Fever". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03875560. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*